Trial
NCT00949988
A Study of Dasatinib and Rituximab for Relapsed/Refractory Chronic Lymphocytic Leukemia
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of California, San Diego
Collaborators
Bristol-Myers Squibb
Condition
Chronic Lymphocytic Leukemia
Intervention
Dasatinib and Rituximab
Why stopped
Three subjects were enrolled and all three subjects withdrew.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-08-14